Similar articles

• Just when you thought the fluorouracil debate was over: S-1 and gastric cancer.

  Ilson D. Ilson D. J Clin Oncol. 2005 Oct 1;23(28):6826-8. doi: 10.1200/JCO.2005.06.006. Epub 2005 Sep 6. J Clin Oncol. 2005. PMID: 16145059 No abstract available.
• Neoadjuvant S-1 and cisplatin for gastric carcinoma: there will be more to come.

  Kodera Y. Kodera Y. Gastric Cancer. 2006;9(2):72-3. doi: 10.1007/s10120-006-0376-5. Gastric Cancer. 2006. PMID: 16767360 No abstract available.
• S-1 with leucovorin and oxaliplatin for advanced gastric cancer.

  Ter Veer E, van Oijen MGH, van Laarhoven HWM. Ter Veer E, et al. Lancet Oncol. 2016 Feb;17(2):e41. doi: 10.1016/S1470-2045(16)00005-X. Lancet Oncol. 2016. PMID: 26868348 No abstract available.
• [Clinical development of S-1 (TS-1) for advanced gastric cancer].

  Wasaburo K, Tanabe S, Higuchi K, Sasaki T, Nakayama N, Mihara S, Nakatani K, Nishimura K, Shimoda T, Azuma M, Katada C, Hanaoka N, Naruke A, Ryu T, Ishido K, Saigenji K. Wasaburo K, et al. Gan To Kagaku Ryoho. 2006 Jun;33 Suppl 1:57-63. Gan To Kagaku Ryoho. 2006. PMID: 16897973 Review. Japanese.
• [Clinical development of chemotherapy for advanced gastric cancer].

  Sato A, Matsukawa M. Sato A, et al. Nihon Shokakibyo Gakkai Zasshi. 2007 Feb;104(2):186-93. Nihon Shokakibyo Gakkai Zasshi. 2007. PMID: 17283412 Review. Japanese. No abstract available.